Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.236NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XQNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.59NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.395NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.120.2.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.416.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.532NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.408NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XHNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EE.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.52NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.4.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.58NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.631NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.627NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.519NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.514NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.87NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAPNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.4.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.6.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.47.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DN.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DJ.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BW.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.10.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FW.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CA.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.46NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CU.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CA.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.83NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.4.2.4 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used